ReviewFrontiers in pharmacology2026

15-hydroxyeicosatetraenoic acid (15-HETE)-GPR39 axis: a potential therapeutic target in eosinophilic asthma.

Andrew Engel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.